# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed May 17, 2012

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2012-05-17
- Accepted by EDGAR: May 17, 2012, 20:10 ET
- Period: 2012-05-16
- Accession: 0001104659-12-038145
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000110465912038145/a12-12450_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000110465912038145/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000110465912038145/a12-12450_18k.htm

Filed May 17, 2012.
Source: SEC EDGAR, the filing index for accession 0001104659-12-038145. Last ingested by Listed: Nov 6, 2026, 12:56 ET. No prices; not investment advice.
